Japan-based Santen acquires US ophthalmic company Eyevance Pharmaceuticals
Santen acquisition of Eyevance : Santen Pharmaceutical, a Japanese pharma company specialized in ophthalmology, has acquired US ophthalmic company Eyevance Pharmaceuticals for $225 million in cash. The acquisition was undertaken by the company’s fully-owned subsidiary Santen Holdings U.S. Established only a couple of years ago, Eyevance Pharmaceuticals develops and commercializes topical ophthalmic products that target the […]